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Lower extremity ulcers that are associated with
venous insufficiency have been estimated to affect
0.2% to 1% of the population in developed coun-
tries.1 Although these ulcers are rarely a cause of
amputation, patient debilitation and discomfort are
significant. The chronic, recurring nature of these
ulcers prohibits many patients from working or
enjoying an active lifestyle. The standard therapy for
ulcers that are associated with venous insufficiency
has emphasized nonoperative techniques, including
leg elevation, compression therapy with Unna’s
paste boot or elastic wraps, and patient education.2
Recently, several techniques have been reported to
improve healing rates or to reduce the risk of recur-
rence for venous leg ulcers. These techniques
include subfascial endoscopic perforator surgery
(SEPS)3 and the application of allogeneic cultured
human skin construct.4 Although promising, these
techniques are expensive, which raises the question
of appropriate patient selection to maximize cost
efficacy. This report reviews the factors that are asso-
ciated with the healing of leg ulcers and the associ-
ated costs in a large group of patients to help deter-
mine which patients are well served with outpatient
compression techniques and who might benefit
from adjuvant techniques of treatment.
PATIENTS AND METHODS
Patients who were referred to the University of
North Carolina wound care clinic with leg ulcers
and clinical or duplex scan evidence of chronic
venous insufficiency (CVI) were followed prospec-
tively with the following protocol: all the patients
underwent a history and physical examination to
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Objective: Although newer techniques to promote the healing of leg ulcers associated
with chronic venous insufficiency are promising, improved healing rates and cost effec-
tiveness are unproven. We prospectively followed a series of patients who underwent
treatment with outpatient compression for venous stasis ulcers without adjuvant tech-
niques to determine healing rates and costs of treatment.
Methods: Two hundred fifty-two patients with clinical or duplex scan evidence of chron-
ic venous insufficiency and active leg ulcers underwent treatment with ambulatory com-
pression techniques. The patients were prospectively followed with wound measure-
ments at 1-week to 2-week intervals, and the factors that were associated with delayed
healing were determined.
Results: Of all the ulcers, 57% were healed at 10 weeks of treatment and 75% were healed
at 16 weeks. Ultimately, 96% of the ulcers healed, and only 1 major amputation was
necessitated (0.4%). Initial ulcer size and moderate arterial insufficiency (ankle brachial
index, 0.5 to 0.8; n = 34) were factors that were independently associated with delayed
healing (P < .01). Patient age, ulcer duration before treatment, and morbid obesity did
not significantly affect healing times. The cost of 10 weeks of outpatient treatment with
compression techniques ranged from $1444 to $2711.
Conclusion: The treatment of venous stasis ulcers with compression techniques results in
reliable, cost-effective healing in most patients. Current adjuvant techniques may prove
to be useful but are likely to be cost effective only in a minority of cases, particularly in
patients with large initial ulcer size or arterial insufficiency. (J Vasc Surg 1999;30:491-8.)
491
From the Department of Surgery, University of North Carolina
at Chapel Hill School of Medicine.
Presented at the Twenty-third Annual Meeting of The Southern
Association for Vascular Surgery, Naples, Fla, Jan 27–30, 1999.
Reprint requests: Dr William A. Marston, Division of Vascular
Surgery, UNC Department of Surgery, 210 Burnett-Womack,
CB #7210, Chapel Hill, NC 27599-7210.
Copyright © 1999 by the Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/6/100055
determine causes of ulceration. Patient information,
including age, sex, history of diabetes or morbid
obesity, ulcer duration before treatment, history of
multiple previous ulcers, and peripheral arterial dis-
ease, was recorded. The presence of lower extremity
edema, hyperpigmentation, and stasis dermatitis in
the gaiter region were all necessary to make a clini-
cal diagnosis of CVI. Ulcer location, size, and depth
were documented at the initial visit with wound
tracings, and planimetry was performed to obtain
measurement of ulcer area. At subsequent visits,
ulcer size in two maximal dimensions was recorded.
When patients were seen with bilateral leg ulcers,
each limb was considered separately, and if multiple
ulcers were present on a limb, only one ulcer, the
largest, was chosen as the index ulcer for measure-
ment and determination of healing time.
Patients with no palpable pedal pulses under-
went Doppler scan waveform analysis and segmental
pressure measurement to determine the degree of
arterial insufficiency (AI). Patients with an ankle
brachial index (ABI) of greater than 0.8 were con-
sidered to have an adequate arterial supply to heal
and comprised the isolated venous insufficiency
group (no AI group). Patients with evidence of
venous insufficiency and an ABI of 0.5 to 0.8 who
were not candidates for revascularization because of
medical comorbidity comprised the combined arter-
ial and venous insufficiency group (AI group).
Patients with an ABI of less than 0.5 were excluded
from the data analysis and were considered for revas-
cularization.
Patients underwent evaluation of the venous
anatomy with duplex ultrasound scanning and a
rapid deflation cuff unless contraindicated by obesi-
ty or inability to cooperate with the study. With cri-
teria that were established previously, the deep,
superficial, and perforator systems were systematical-
ly examined for reflux in the standing position.5 The
anatomic pattern of CVI was identified, which
allowed comparison with patient outcome. During
the time period of this study, the authors did not
perform venous surgery on any patients before ulcer
healing.
Patients with venous insufficiency alone under-
went treatment with one of two forms of compression
treatment at the discretion of the attending physician.
Unna’s paste boot (Medicopaste, Graham-Field,
Hauppauge, NY) was applied from the foot to the
knee and was covered with an elastic crepe bandage
(Coban, 3M, St Paul, Minn). Four-layer, sustained
compression wraps (Profore, Smith & Nephew, Largo,
Fla) were applied as previously described to achieve 40
mm Hg of sustained compression at the ankle.6 In all
the patients, a primary cover for the ulcer was chosen
on the basis of the amount of drainage from the ulcer.
At the discretion of the treating physician, the patients
who were judged to have more extensive drainage
underwent treatment with absorptive foam dressings
as a primary cover, such as Sof-foam (Johnson &
Johnson Medical Inc, Arlington, Tex) or Allevyn
(Smith & Nephew). These foam dressings allowed less
frequent changes of the compression wrap or Unna’s
paste boot. Patients with managable drainage under-
went treatment with no primary cover with Unna’s
paste boot or with the primary layer contained in the
Profore kit. Extensive education concerning leg eleva-
tion, wound care, and venous disease was performed
for each patient. Patients with combined arterial and
venous insufficiency (ABI, 0.5 to 0.8) underwent
treatment with a three-layer compression wrap, omit-
ting one layer of elastic compression from the four-
layer protocol to achieve a reduced level of compres-
sion at the ankle (25 to 30 mm Hg, from manufactur-
er’s unpublished data).
The dressings were applied for a maximum of 1
week, with more frequent changes necessitated in
patients with excessive ulcer drainage. The patients
returned to the clinic for wound examination every 1
to 3 weeks, depending on home health nursing
involvement. Home health nursing was used in
patients who required dressing changes between clinic
visits. Those patients who did not return to the clinic
for at least 6 weeks of treatment were considered to be
lost to follow-up examination and were excluded from
the data analysis. The patients were followed until the
ulcers were healed with complete re-epithelialization
of the wound. Once the ulcers were healed, the
patients were fitted for knee-high compression gar-
ments, with 30 to 40 mm Hg of compression at the
ankle for patients with venous insufficiency alone and
20 to 30 mm Hg for patients with combined arterial
and venous insufficiency. Patient follow-up examina-
tion occurred at 6-month intervals after healing to
renew compression hose and reinforce education.
The costs that were associated with the treat-
ment of leg ulcers were tabulated on the basis of
Medicare reimbursement as follows: physician reim-
bursement for evaluation and procedures and hospi-
tal reimbursement for any blood, vascular laborato-
ry, or other tests were determined by the actual
amount reimbursed by Medicare for each charge.
The cost of wound dressing materials was based on
the amount paid by the hospital for components
used in the prescribed dressing. The cost of home
health nursing was determined for each patient on
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the basis of the number of home health visits times
the usual Medicare allowable per visit of $120 in
North Carolina.
Data analysis. The following risk factors were
analyzed for association with ulcer healing with multi-
variate discriminate analysis with the StatView statisti-
cal analysis software package (Abacus Concepts,
Berkeley, Calif): patient age, sex, diabetes, morbid
obesity, initial ulcer size, AI, ulcer duration before
treatment, ulcer location, site of venous reflux, and
type of compression. The healing times for individual
factors were compared with Kaplan-Meier method
curves and the log-rank test, with a P value of less than
.05 necessary for statistical significance in all cases.7
RESULTS
Study population. Two hundred twenty-seven
patients with 264 ulcerated limbs that were associat-
ed with venous insufficiency underwent evaluation
from July 1995 to July 1998. Ten patients were lost
to examination before 6 weeks of therapy and were
excluded, which left 252 ulcers in 217 patients for
analysis. Thirty-five patients had bilateral leg ulcers.
The patient characteristics are summarized in Table I.
The average ulcer size was 24.6 ± 63.2 cm2 (range,
1 to 600 cm2). At initial examination, 91 ulcers
(36.1%) measured less than 5 cm2, 94 ulcers (37.3%)
were 5 to 20 cm2, and 67 ulcers (26.6%) were greater
than 20 cm2 in size. One hundred thirty-eight limbs in
116 patients underwent venous duplex scan studies for
reflux, with the distribution of disease listed in Table
II. Deep reflux was shown in 71% of the limbs. The
remaining 29% of the limbs had superficial or superfi-
cial and perforator incompetence, which could poten-
tially be corrected with superficial vein removal and
SEPS if necessary. Overall, 56.5% of the limbs had
superficial reflux, and 17.4% were found to have
incompetent perforator veins.
Healing rates. Sixty-nine percent of the patients
underwent treatment with four-layer compression
bandages, 13% underwent treatment with three-layer
compression bandages for combined arterial and
venous insufficiency, and 18% underwent treatment
with Unna’s paste boots. Time to healing in the entire
population of 252 leg ulcers on the basis of life-table
analysis is illustrated in Fig 1. Fifty-seven percent of
the ulcers were healed at 10 weeks, and 75% were
healed at 16 weeks of treatment. At 1 year, 96% of all
the ulcers were healed, and only one major amputa-
tion was necessitated (0.4%). Of the 10 unhealed
ulcers, seven were significantly improved, two were
unchanged, and one worsened in a patient with com-
bined arterial and venous insufficiency and necesssi-
tated amputation. This patient was considered for
arterial revascularization but was not a surgical candi-
date because of severe medical comorbidity. Fifteen
patients were hospitalized during the study period for
leg ulcer–related complications, including infection,
uncontrolled edema, or both.
Risk factor analysis. With multivariate analysis,
the only factors to independently effect healing time
were initial ulcer size (P < .001) and AI (P < .01).
When the effect of the site of reflux on healing was
examined, the patients with superficial or superficial
and perforator incompetence had ulcers that were
found to heal in 8.2 ± 5.8 weeks as compared with
13.7 ± 8.8 weeks for patients with deep venous
incompetence alone. This difference was not signifi-
cant when corrected for initial ulcer size (P = .09).
The effect of initial ulcer size on time of healing
is illustrated in Fig 2. Ulcers that were less than 5 cm2
at initial presentation healed significantly faster (77%
at 10 weeks) than ulcers measuring 5 to 20 cm2 (61%
at 10 weeks; P < .025, with log-rank test). Ulcers that
were larger than 20 cm2 at presentation were associ-
ated with significantly delayed healing (P < .001, as
compared with both other groups), with only 22%
healed at 10 weeks. Although 89% of the large ulcers
eventually healed, 21 weeks of treatment were neces-
sary to heal 50%, and many ulcers needed required
treatment for more than 9 months.
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Table I. Patient characteristics
Characteristics
Average age (years) 61.4 
(range, 21 to 91)
Percent male 53%
Average time ulcer present before 7.4
treatment (months)
No. of patients with:
Diabetes 32 (14.1%)
Morbid obesity (>50% above ideal weight) 44 (19.4%)
Arterial insufficiency (ABI, 0.5 to 0.8) 34 (15.0%)
ABI, Ankle brachial index.
Table II. Anatomic distribution of venous reflux
in 138 limbs
Reflux site No. of limbs
Deep system reflux alone 60 (43.5%)
Deep and superficial reflux 29 (21.0%)
Deep, perforator, and superficial reflux 9 (6.5%)
Superficial system reflux alone 25 (18.1%)
Superficial and perforator reflux 15 (10.9%)
The effect of AI on ulcer healing time is illus-
trated in Fig 3. In the no AI group, 63% of the ulcers
healed after 10 weeks of treatment as compared with
only 25% of the ulcers in the AI group (P < .005,
with log-rank test). Eighty-five percent of the ulcers
in the AI group were eventually healed with three-
layer compression dressings, with 19 weeks of treat-
ment necessary to heal 50% of the ulcers.
Ulcer recurrence. After ulcer healing, follow-
up examination was obtained in 202 ulcerated limbs.
In these limbs, the ulcer recurrence rate with life-
table method was 21% ± 3.7% at 12 months, 29% ±
5.8% at 24 months, and 38% ± 10.5% at 36 months.
Cost efficacy. The average cost for 10 weeks of
outpatient treatment with the outlined protocol was
$2198 ± $445, ranging from $1444 to $2711. In
patients who did not require home health nursing
visits, physician reimbursement comprised 48% of the
total cost, peripheral vascular and other laboratory
testing comprised 19%, and wound dressing materi-
als comprised 33%. In patients who required home
health nursing (56% of the patients), physician reim-
bursement comprised 24% of the total cost, laborato-
ry tests comprised 14%, and home health reimburse-
ment comprised 62%. The factors that were most
closely associated with increased treatment costs were
ulcer size and the amount of ulcer drainage. Patients
with larger, heavily draining ulcers initially required
dressing changes two to three times per week, which
necessitated increased home health use, resulting in a
significantly increased cost per week of treatment.
The cost to heal ulcers less than 5 cm2 averaged
$1327, ulcers 5 to 20 cm2 averaged $1978, and
ulcers more than 20 cm2 averaged $5289.
DISCUSSION
The standard treatment for lower extremity ulcers
that are associated with venous insufficiency has
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Fig 1. Life-table analysis for time to healing for all 252 ulcers.
emphasized the use of outpatient compression meth-
ods, elevation, and patient education. Various forms
of compression therapy have been used throughout
history for the treatment of venous leg ulcers, but no
randomized trial has been performed that compared
it with wound care without compression. Because
compression has become the standard of care, it is
unlikely that such a study will be performed given the
ethical problems of the control group. With ambula-
tory elastic compression hose, Mayberry et al8
achieved healing at a mean time of 5.3 months.
Compliance with the treatment protocol was identi-
fied as the primary factor relating to time of healing
and recurrent ulceration. Erickson et al9 reported sim-
ilar results in the treatment of 99 ulcers with Unna’s
paste boot or ambulatory compression hose. Median
time to healing was 3.4 months, and normal venous
refill time and patient compliance were associated
with faster healing. Recurrent ulceration occurred in
57% of patients. Other factors that have been associ-
ated with delayed ulcer healing have been increased
age, larger initial ulcer size,10 popliteal vein reflux,11
and poor response to the initial 2 weeks of compres-
sion treatment.12
Recent developments for the treatment of lower
extremity ulcers that are associated with venous
insufficiency include SEPS and the application of
allogeneic cultured human skin construct. SEPS has
been reported to accelerate the healing rate of venous
leg ulcers and to possibly reduce the incidence of
recurrence.13,14 Cultured human skin construct was
found, in a multicenter randomized trial, to acceler-
ate the healing rate of larger ulcers and those present
for extended periods of time.4 However, these tech-
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Fig 2. Life-table analysis for time to healing for ulcers on basis of initial size. All curves are
significantly different with log-rank testing with P < .025.
niques are associated with disadvantages. In the
prospective randomized trial, Falanga et al4 used an
average of 3.4 applications of human skin construct
per ulcer in the treatment arm. At more than $1000
per application, this adds significant cost to ulcer
care. Although SEPS is a relatively low-risk proce-
dure, the North American registry reported compli-
cations, including superficial thrombophlebitis,
wound infection, and saphenous neuralgia, in a small
number of patients.3
In this report, we present the results of the
ambulatory compression treatment of a large series
of patients with ulcers that were associated with
venous insufficiency. We hope to identify the
patients who would not be expected to heal in a rea-
sonable period of time with this protocol. The
potential benefits of ambulatory compression meth-
ods include their wide applicability, minimal risk,
and cost efficacy. However, compression treatment
does not address the cause of ulceration, and recur-
rence is frequent, depending on patient compliance
with chronic use of compression stockings.
Although no clear differences have been proven
for different compression systems,2 we use four-layer
compression bandaging in most patients because we
believe edema is better managed and patient com-
fort is increased. We found that 96% of ulcers that
were associated with venous insufficiency were
healed within 1 year and that 50% of ulcers of less
than 20 cm2 in size with normal arterial supply were
healed with 7 weeks of treatment at an average cost
of less than $2000. We suggest that, unless other
JOURNAL OF VASCULAR SURGERY
496 Marston et al September 1999
Fig 3. Life-table analysis for time to healing for ulcers with arterial insufficiency (AI) com-
pared with ulcers without arterial insufficiency (no AI). Curves are significantly different with
log-rank testing (P < .005).
techniques provide marked acceleration of healing,
smaller ulcers without AI are best treated with
ambulatory compression protocols.
Larger ulcers and those with AI were associated
with significantly delayed healing. It is in these groups
that significant savings in healing time and cost are
possible with adjuvant techniques. Clearly, patients
with significant AI should be considered for revascu-
larization if possible. When revascularization is not
possible, the results of this study suggest that most
patients can be healed with modified compression to
apply a reduced pressure at the ankle. Although cul-
tured human skin construct was reported to improve
healing rates, the cost of this treatment is high
(>$1000 for one 7 · 7–cm piece) and markedly
increases in larger ulcers because more product is
necessitated. Healing rates for venous ulcers after
SEPS have not been prospectively compared with
healing rates for ulcers without SEPS. In the subset of
patients that we studied with duplex ultrasound scan-
ning, 17.4% were found to have perforator reflux and
were potential candidates for SEPS.
Given the high incidence of recurrent ulceration
after ulcer healing in this and other reports, tech-
niques that reduce or correct venous reflux and asso-
ciated hypertension may provide significant benefit
to these patients. Scriven et al15 reported that saphe-
nous vein disconnection improved venous function
and healed venous ulcers without compression ban-
daging in 16 patients with saphenous reflux alone. It
is not yet clear whether SEPS procedures will result
in a reduced incidence of ulcer recurrence. Sparks et
al13 reported no ulcer recurrence after SEPS at an
average follow-up period of 8.6 months, but
Glovizki et al16 reported the incidence of new or
recurrent ulceration to be 16% at 12 months and
28% at 24 months of follow-up.16 We believe that a
prospective trial that randomizes patients to com-
pression therapy with or without SEPS in patients
with incompetent perforator veins would help clari-
fy the role of SEPS. We currently perform this pro-
cedure in patients with recurrent ulceration who
have incompetent perforators and a competent deep
venous system. Superficial venous stripping is per-
formed at the same time as SEPS when indicated.
The trend towards slower healing in patients with
deep venous insufficiency is interesting. Given the lim-
ited number of patients studied, the lack of a signifi-
cant difference may represent a type II error. Other
studies have identified global reflux and popliteal vein
reflux as associated with delayed healing.9,11
Duration of ulceration before treatment did not
independently correlate with healing time. This is
likely because size was the predominant factor.
Neglected ulcers were usually larger by the time of
presentation for treatment. If an ulcer was not treat-
ed appropriately for a prolonged time but remained
small, the patient typically healed rapidly after com-
pression therapy was applied. In this study, we did
not address the relationship between ulcer healing in
the initial 2 weeks of treatment and time of healing.
In conclusion, ambulatory compression treat-
ment remains a reliable, cost-effective method of
treatment for patients with ulcers associated with
venous insufficiency, particularly those with smaller,
well-vascularized ulcers. With protocols such as the
one outlined previously, most ulcers are healed with-
in 10 weeks of therapy at a reasonable cost. Larger
ulcers and those associated with AI (31% of the
ulcers in this study) often experience delayed healing
and may benefit significantly from adjuvant healing
techniques, such as human skin construct and arter-
ial revascularization when possible. Recurrence rates
after healing were high despite persistent efforts at
chronic limb compression and patient education,
which emphasizes the need to further define
whether corrective venous surgery, such as SEPS or
superficial venous stripping when possible, will
reduce the risk of ulcer recurrence.
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Dr F. Noel Parent III (Norfolk, Va). The essence of
this anecdotal series of venous ulcers treated with com-
pression wrapping on an outpatient basis confirms that
almost all ulcers will heal with an Unna’s paste boot or a
compression wrap if given enough time. The majority of
ulcers heal within 4 months, and the cost for this treat-
ment regimen is reasonable. Only large initial ulcer size
and moderate arterial insufficiency were independently
associated with a longer healing time. It is in this group of
difficult-to-treat ulcers that the authors suggest those
adjuvant surgical therapies, such as SEPS and human skin
equivalent, which may be more cost effective than pro-
longed Unna’s paste boot treatment.
The desired outcome is ulcer healing without recur-
rence. Compression therapy is well known to achieve ulcer
healing. However, unless the underlying venous hemody-
namics can be improved upon, recurrent ulcers are the
rule. Stated in the presentation and manuscript but absent
from your abstract is a recurrence rate of 25.6% at 12
months and 36.5% at 30-month follow-up. And I think it
is obvious that any cost savings will quickly evaporate if
long-term ulcer control is not achieved.
In this series, superficial venous reflux was found in
56.5% of cases, but there is no mention of any surgical
treatment for it. Some studies have shown that reflux in
the superficial venous system may overload the capacitance
of the venous system, resulting in deep venous reflux.
After superficial vein stripping, the venous capacitance is
restored to normal and the deep and perforator vein reflux
may resolve. My only criticism would be of giving up com-
pression boot therapy for SEPS or human skin equivalent
before treating any superficial vein reflux by vein stripping.
That leaves me with three simple questions. Do the
duplex ultrasound scan data about the deep, superficial,
and perforator veins guide your therapy? How do you pre-
fer to treat recurrent ulcers? And what do you think
should be done to prevent ulcer recurrence?
Thank you.
Dr William A. Marston. Thank you very much, Dr
Parent, and I think those are important questions. Our
point is not to suggest that surgery to anatomically correct
superficial or perforator lesions, if possible, should not be
done. We fully agree with that. After ulcer healing in
patients with superficial or perforator incompetence, we
attempted to correct these systems if the patient would
agree to surgery. If the patient had deep venous insuffi-
ciency alone, we have been more reluctant to do that type
of surgery, except for young patients who had chronically
recurring ulcers. Then, we would attempt to do a venous
valve transplantation or, if possible, correction. But that is
relatively rare in our population. We use the duplex ultra-
sound scan data to guide that process by mapping all three
systems for the sites of reflux.
I think the main point of our presentation here,
though, is that if you use a religious program of compres-
sion therapy, you can get the ulcers healed initially, and
then your job is preventing recurrence. It does not change
the high recurrence rate and it does not lessen the impor-
tance of that job, which is truly the important thing in the
long run for the patients.
When considering the utility of SEPS, the crux of the
matter is whether it will reduce the ulcer recurrence rate,
and I do not think we know that yet. Superficial venous
surgery has been shown in some studies to reduce recur-
rence rates, so we are a real proponent of that as well.
Thank you.
DISCUSSION
